We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pilot Offers Chance to Get EMA Advice on Postmarket Study Design
Pilot Offers Chance to Get EMA Advice on Postmarket Study Design
August 10, 2015
The European Medicines Agency is launching a 12-month pilot program to improve the usefulness of postmarket safety data by providing drugmakers with targeted advice on postmarket study design.